Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ContraFect Corporation (CFRX)

  • Company Report
  • March 31, 2023, 23:15 UTC
  • 40

New SEC Form for ContraFect Corporation

Comment Full text

Pieris Pharmaceuticals Inc. (PIRS)

  • Company Report
  • March 31, 2023, 23:14 UTC
  • 37

New SEC Form for Pieris Pharmaceuticals, Inc.

Comment Full text

bioAffinity Technologies Inc. (BIAF)

  • Company Report
  • March 31, 2023, 22:45 UTC
  • 39

New SEC Form for bioAffinity Technologies, Inc.

Comment Full text

Artelo Biosciences Inc. (ARTL)

  • Company Report
  • March 31, 2023, 15:09 UTC
  • 41

New SEC Form for Artelo Biosciences, Inc.

Comment Full text

SCYNEXIS Inc. (SCYX)

  • Company Report
  • March 31, 2023, 14:20 UTC
  • 40

New SEC Form for SCYNEXIS, Inc.

Comment Full text

Inhibikase Therapeutics Inc. (IKT)

  • Company Report
  • March 31, 2023, 14:19 UTC
  • 38

New SEC Form for Inhibikase Therapeutics, Inc.

Comment Full text

Journey Medical Corporation (DERM)

  • Company Report
  • March 31, 2023, 13:35 UTC
  • 41

New SEC Form for Journey Medical Corporation

Comment Full text

Unicycive Therapeutics Inc. (UNCY)

  • Company Report
  • March 31, 2023, 13:25 UTC
  • 40

New SEC Form for Unicycive Therapeutics, Inc.

Comment Full text

OmniAb Inc (OABI)

  • Company Report
  • March 31, 2023, 01:25 UTC
  • 39

OmniAb - 2022 Annual Report

Comment Full text

Pasithea Therapeutics Corp. (KTTA)

  • Company Report
  • March 31, 2023, 00:40 UTC
  • 42

New SEC Form for Pasithea Therapeutics Corp.

Comment Full text
  • Previous
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next

Search

News categories

  • Technical Exchange News(9040)
  • Event(407)
  • SEC News(142696)
  • FDA Approval(8415)
  • Company Report(721)
  • Business News(99959)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin